The Journal of Blood Disorders and Treatment is peer-reviewed, open access, scholarly journal aimed at publishing the latest advancements in the field, enriching our understanding of blood disorders such as: Clotting Disorders, Anemias, Hematologic Malignancies, Coagulopathies, Thrombotic Disorders, Hemoglobinopathies, Lymphoproliferative Disorders, Plasma Cell Disorders,and Immunologic and Genetic Disorders of the blood. The journal offers a platform for dissemination of information on all aspects of blood-related disorders such as prevention, diagnosis, and management of these disorders.
The scope of the journal includes, but is not restricted to diseases such as: Anemia, Neutropenia, Hemophilia, Thalassemia, Antiphospholipid Syndrome,Lupus, Sickle Cell Disease, Leukemia, Lymphoma, Myeloma, Von Willebrand Disease, Autoimmune Lymphoproliferative Syndrome,and Deep Vein Thrombosis. Special emphasis is placed on the treatment and management strategies such as: Thrombolytics, Thrombectomy, Blood Transfusion, Stem Cell Transplantation, Artificial Cells, Blood Substitutes, Recombinant Clotting Factors,Gene Therapy, and Chemo and Radiotherapy.